An analysis of five clear cell papillary cystadenomas of mesosalpinx and broad ligament: Four associated with von Hippel-Lindau disease and one aggressive sporadic type

Histopathology

Volumn 60, Issue 5, 2012, Pages 748-757

  Nogales, Francisco F ^a   Goyenaga, Pablo ^a   Preda, Ovidiu ^a   Nicolae, Alina ^a   Vieites, Begoña ^b   Ruiz Marcellan, Maria Carmen ^c   Pedrosa, Alberto ^d   Merino, Maria J ^e  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Complejo Hospitalario Universitario ^*  (Spain)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Clear cell papillary cystadenoma; Clear cell papillary renal cell carcinoma; Mesonephric rests; Mesosalpinx; Sporadic; Von Hippel Lindau disease

Indexed keywords

CA 125 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; TRANSCRIPTION FACTOR PAX2; VIMENTIN; VON HIPPEL LINDAU PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLEEDING; CLEAR CELL PAPILLARY CYSTADENOMA; CLINICAL ARTICLE; CYSTADENOMA; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GENETIC MARKER; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; SCAR FORMATION; THROMBOSIS; TUMOR SUPPRESSOR GENE; VASCULARIZATION; VON HIPPEL LINDAU DISEASE;

ADULT; BROAD LIGAMENT; CYSTADENOMA, PAPILLARY; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN; YOUNG ADULT;

EID: 84859006564     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04151.x     Document Type: Article

References (26)

1. Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur. J. Hum. Genet. 2011; 19; 617-623.
2. Gersell DJ, King TC. Papillary cystadenoma of the mesosalpinx in von Hippel-Lindau disease. Am. J. Surg. Pathol. 1988; 12; 145-149.
3. Funk KC, Heiken JP. Papillary cystadenoma of the broad ligament in a patient with von Hippel-Lindau disease. Am. J. Roentgenol. 1989; 153; 527-528.
4. Korn WT, Schatzki SC, DiSciullo AJ et al. Papillary cystadenoma of the broad ligament in von Hippel-Lindau disease. Am. J. Obstet. Gynecol. 1990; 163; 596-598.
5. Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am. J. Surg. Pathol. 1994; 18; 1254-1260.
6. Werness BA, Guccion JG. Tumor of the broad ligament in von Hippel-Lindau disease of probable mullerian origin. Int. J. Gynecol. Pathol. 1997; 16; 282-285.
7. Aydin H, Young RH, Ronnett BM et al. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma. Am. J. Surg. Pathol. 2005; 29; 520-523.
8. Zanotelli DB, Bruder E, Wight E et al. Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease. Arch. Gynecol. Obstet. 2010; 282; 343-346.
9. de Paulsen N, Brychzy A, Fournier MC et al. Role of transforming growth factor-alpha in von Hippel-Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc. Natl Acad. Sci. USA 2001; 98; 1387-1392.
10. Frew IJ, Minola A, Georgiev S et al. Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. Mol. Cell. Biol. 2008; 28; 4536-4548.
11. Bing Z, Pasha TL, Acs G et al. Cytoplasmic overexpression of WT-1 in gastrointestinal stromal tumor and other soft tissue tumors. Appl. Immunohistochem. Mol. Morphol. 2008; 16; 316-321.
12. Odrzywolski KJ, Mukhopadhyay S. Papillary cystadenoma of the epididymis. Arch. Pathol. Lab. Med. 2010; 134; 630-633.
13. Wagner M, Browne HN, Marston Linehan W et al. Lipid cell tumors in two women with von Hippel-Lindau syndrome. Obstet. Gynecol. 2010; 116(Suppl. 2); 535-539.
14. Hayden MG, Gephart R, Kalanithi P et al. Von Hippel-Lindau disease in pregnancy: a brief review. J. Clin. Neurosci. 2009; 16; 611-613.
15. Young RH, Welch WR, Dickersin GR et al. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982; 50; 1384-1402.
16. Plata C, Algaba F, Andujar M et al. Large cell calcifying Sertoli cell tumour of the testis. Histopathology 1995; 26; 255-259.
17. Kurihara K, Oka A, Mannami M et al. Papillary adenocarcinoma of the epididymis. Acta Pathol. Jpn. 1993; 43; 440-443.
18. Gobbo S, Eble JN, Grignon DJ et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am. J. Surg. Pathol. 2008; 32; 1239-1245.
19. Aydin H, Chen L, Cheng L et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am. J. Surg. Pathol. 2010; 34; 1608-1621.
20. Rohan SM, Xiao Y, Liang Y et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod. Pathol. 2011; 24; 1207-1220.
21. Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch. Pathol. Lab. Med. 2011; 135; 92-109.
22. Gilcrease MZ, Schmidt L, Zbar B et al. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. Hum. Pathol. 1995; 26; 1341-1346.
23. Ordi J, Romagosa C, Tavassoli FA et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am. J. Surg. Pathol. 2003; 27; 178-186.
24. Adam J, Couturier J, Molinie V et al. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 2011; 58; 1064-1071.
25. Rabban JT, McAlhany S, Lerwill MF et al. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am. J. Surg. Pathol. 2010; 34; 137-146.
26. Sakashita N, Takeya M, Kishida T et al. Expression of von Hippel-Lindau protein in normal and pathological human tissues. Histochem. J. 1999; 31; 133-144.